93249-62-8

Basic information

• Product Name: 2-HYDROXY-5-(TRIFLUOROMETHOXY)BENZALDEHYDE
• Synonyms: BUTTPARK 22\04-61;5-(TRIFLUOROMETHOXY)SALICYLALDEHYDE;2-HYDROXY-5-(TRIFLUOROMETHOXY)BENZALDEHYDE;5-(Trifloromethoxy)salicylaldehyde;20HYDROXY-5-(TRIFLUOROMETHOXY)BENZALDEHYDE;2-Hydroxy-5-(trifluoromethoxy)benzaldehyde 99%;2-Hydroxy-5-(trifluoromethoxy)benzaldehyde99%;2-Hydroxy-5-(trifluoromethoxy)benzaldehyde, 98+%
• CAS NO: 93249-62-8
• Molecular Formula: C₈H₅F₃O₃
• Molecular Weight: 206.12
• EINECS: -0
• Product Categories: Aromatic Aldehydes & Derivatives (substituted)
• Mol File: 93249-62-8.mol

Chemical Properties

• Melting Point: 31-33 °C(lit.)
• Boiling Point: 82 °C60 mm Hg(lit.)
• Flash Point: >230 °F
• Appearance: White to pale yellow/Low Melting Solid
• Density: 1.4251 (estimate)
• Vapor Pressure: 0.0894mmHg at 25°C
• Refractive Index: 1.512
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• PKA: 7.56±0.18(Predicted)
• Sensitive: Air Sensitive
• BRN: 7023825
• CAS DataBase Reference: 2-HYDROXY-5-(TRIFLUOROMETHOXY)BENZALDEHYDE(CAS DataBase Reference)
• NIST Chemistry Reference: 2-HYDROXY-5-(TRIFLUOROMETHOXY)BENZALDEHYDE(93249-62-8)
• EPA Substance Registry System: 2-HYDROXY-5-(TRIFLUOROMETHOXY)BENZALDEHYDE(93249-62-8)

Safety Data

• Hazard Codes: Xi
• Statements: 36/37/38
• Safety Statements: 26-37/39
• WGK Germany: 3
• HazardClass: IRRITANT
• Hazardous Substances Data: 93249-62-8(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
2-Hydroxy-5-(trifluoromethoxy)benzaldehyde is used as a key intermediate in the synthesis of various pharmaceutical compounds, including:
1. 2-[(E)-2-hydroxy-5-(trifluoromethoxy)benzylideneamino]-4-methylphenol: 2-HYDROXY-5-(TRIFLUOROMETHOXY)BENZALDEHYDE is synthesized using 2-hydroxy-5-(trifluoromethoxy)benzaldehyde as a starting material, and it may have potential applications in drug development.
2. (E)-2-((3-fluorophenylimino)methyl)-4-(trifluoromethoxy) phenol: Another pharmaceutical compound that can be prepared using 2-hydroxy-5-(trifluoromethoxy)benzaldehyde, which may be utilized in the development of new drugs.
3. 2-[(E)-(naphthalen-2-ylimino)methyl]-4-(trifluoromethoxy) phenol: 2-HYDROXY-5-(TRIFLUOROMETHOXY)BENZALDEHYDE is also synthesized from 2-hydroxy-5-(trifluoromethoxy)benzaldehyde and may have potential applications in the pharmaceutical field.
The specific applications and reasons for using 2-hydroxy-5-(trifluoromethoxy)benzaldehyde in the pharmaceutical industry are related to its role as an intermediate in the synthesis of various compounds with potential therapeutic properties. Further research and development are necessary to fully explore and understand the potential uses of these synthesized compounds in medicine.

InChI:InChI=1/C8H5F3O3/c9-8(10,11)14-6-1-2-7(13)5(3-6)4-12/h1-4,13H

Upstream product

• 710-18-9 1-methoxy-4-(trifluoromethoxy)benzene 
• 50-00-0 formaldehyd 
• 828-27-3 4-Trifluoromethoxyphenol 
• 145742-65-0 2-methoxy-5-(trifluoromethoxy)benzaldehyde 
• 896732-42-6 2-(4-trifluoromethoxy-phenoxy)-tetrahydro-pyran 
• 68-12-2 N,N-dimethyl-formamide 

Downstream Products

• 775330-11-5 2-hydroxy-3-iodo-5-(trifluoromethoxy) benzaldehyde 
• 145742-65-0 2-methoxy-5-(trifluoromethoxy)benzaldehyde 
• 1345256-39-4 (E)-2-[(2-chlorophenyl)iminomethyl]-4-trifluoromethoxyphenol 
• 1356218-38-6 (E)-2-[(2-bromophenyl)iminomethyl]-4-trifluoromethoxyphenol 
• 1581231-15-3 2-(1,4-dioxan-2-yloxy)-5-(trifluoromethoxy)benzaldehyde 
• 1581231-21-1 2-(tetrahydrofuran-2-yloxy)-5-(trifluoromethoxy)benzaldehyde 

Relevant articles and documents

Phosphine-catalyzed sequential (2+3)/(2+4) annulation of γ-vinyl allenoates: Access to the synthesis of chromeno[4,3-: B] pyrroles

A phosphine-catalyzed cascade (2+3)/(2+4) cyclization reaction of γ-vinyl allenoates with aldimine esters has been developed to provide a series of chromeno[4,3-b]pyrrole derivatives that contain three contiguous stereogenic centers. The method gives a good yield, excellent chemoselectivity and diastereoselectivity under mild conditions.

A novel series of 6-substituted 3-(pyrrolidin-1-ylmethyl)chromen-2-ones as selective monoamine oxidase (MAO) A inhibitors

A series of 6-substituted 3-(pyrrolidin-1-ylmethyl)chromen-2-ones (coumarins) have been synthesized and their inhibitory activity to human monoamine oxidase A (MAO A) and B (MAO B) determined. Incorporation of a basic amino function in the C3 position together with substitution at the C6 position produced novel coumarin compounds with selectivity for the MAO A subtype. Substitution in the C6 position with small hydrophilic groups such as hydroxy (19, IC50 = 1.46 μM) or amino (18, IC50 = 3.77 μM) gave the most potent and selective compounds for MAO A. These compounds also showed excellent aqueous solubility properties. Compound 18 [6-amino-3- (pyrrolidin-1-ylmethyl)chromen-2-one] administrated in vivo induced in rat brain a neurotransmitter metabolite profile typical of MAO A inhibition: decreased 3,4-dihydroxyphenylacetic acid (DOPAC) and 5-hydroxyindoleacetic acid (5-HIAA) but increased 3-methoxytyramine (3-MT) levels.

BENZO-FUSED HETEROCYCLIC DERIVATIVES USEFUL AS AGONISTS OF GPR120

The present invention is directed to benzo-fused heterocyclic derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions modulated by GPR120. More particularly, the compounds of the present invention are agonists of GPR120, useful in the treatment of, such as for example, Type II diabetes mellitus.

COMPOUNDS FOR TREATING NEURODEGENERATIVE DISEASES

The invention provides novel tricyclic compounds of Formula (I) that inhibit β- secretase cleavage of APP and are useful as therapeutic agents for treating neurodegenerative diseases.

Benzo[b]thiophene-2-carboxamides and benzo[b]furan-2-carboxamides are potent antagonists of the human H3-receptor

Benzo[b]thiophene-2-carboxamides and benzo[b]furan-2-carboxamides have been found to be antagonists on the human histamine-3-receptor, showing a Ki value of as low as 4 nM.

Pharmaceutical uses for fluoroalkoxybenzylamino derivatives of nitrogen containing heterocycles

The present invention relates to methods of treating various CNS and other disorders by adminstering fluoroalkoxybenzylamino derivatives of nitrogen containing heterocyclic compounds, and specifically, by administering compounds of the formula wherein Q,

Substituted benzopyran derivatives for the treatment of inflammation

A class of benzopyran, derivatives is described for use in treating cyclooxygenase-2 mediated disorders. Compounds of particular interest are defined by Formula I'wherein X, A1, A2, A3, A4, R, R'', R1 and R2 are as described in the specification.

Fluoroalkoxybenzylamino derivatives of nitrogen containing heterocycles

The present invention relates to novel fluoroalkoxybenzylamino derivatives of nitrogen containing heterocyclic compounds, and specifically, to compounds of the formula STR1 wherein Q, X1, X2 and X3 are as defined below. Th

FLUOROALKOXYBENZYLAMINO DERIVATIVES OF NITROGEN CONTAINING HETEROCYCLES

The present invention relates to novel fluoroalkoxybenzylamino derivatives of nitrogen containing heterocyclic compounds, and specifically, to compounds of the formula STR1 wherein Q, X 1, x. sup.2 and X 3 are as defined below. These novel compounds are u

Process for preparing aromatic aldehydes

Aromatic aldehydes are prepared by formylating the corresponding aromatic compounds with urotropine in the presence of hydrogen fluoride. By the described process certain new aromatic aldehydes can be prepared.